AGL-2263

Cat. No. M11329

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Agl-2263 is an inhibitor of insulin receptor and insulin-like growth factor (IGF) receptor.

Molecular Weight	322.27
Formula	C17H10N2O5
CAS Number	638213-98-6
Solubility (25°C)	DMSO ≥ 100 mg/mL
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related Insulin Receptor Products
AVJ16 AVJ16 is a cancer cell migration inhibitor that targets the insulin-like growth factor 2 mRNA binding protein IGF2BP1 to inhibit the migration of H1299 cells with high endogenous IGF2BP1 expression.
[D-Ala2]-GIP (human) [D-Ala2]-GIP (human) is a GIP receptor agonist.
Gastric Inhibitory Peptide, porcine Gastric Inhibitory Peptide, porcine is a glucose-dependent insulinotropic polypeptide, is a 42 amino acid intestinal hormone with effects on fat and glucose metabolism.
(Pro3) GIP, human (Pro3) GIP, human ((Pro3) Gastric Inhibitory Peptide, human) is an efficacious, stable and specific human GIP receptor (hGIPR) full agonist.
GIP (3-42), human GIP (3-42), human acts as a glucose-dependent insulinotropic polypeptide (GIP) receptor antagonist, moderating the insulin secreting and metabolic actions of GIP in vivo.

Catalog